Prof Fiona Russell
@fionarussell.bsky.social
Global child health, infectious diseases, vaccines, evidence based health policy
Director Child & Adolescent Health PhD Program, The University of Melbourne
co-Chair @WSPID ISC
WHO SAGE 2026+
My views
Director Child & Adolescent Health PhD Program, The University of Melbourne
co-Chair @WSPID ISC
WHO SAGE 2026+
My views
Our new paper on the efficacy of 1 dose of Azithromycin given to 2100 pregnant women in labour on infant skin & soft tissue infections in Fiji: blinded, placebo RCT
Congratulations to Maeve, Steph, Tupou & the team
bmcmedicine.biomedcentral.com/articles/10....
Congratulations to Maeve, Steph, Tupou & the team
bmcmedicine.biomedcentral.com/articles/10....
The safety and efficacy of a single dose of oral azithromycin given in labour to prevent skin and soft tissue infections in young infants in Fiji: a randomised controlled trial - BMC Medicine
Background Prophylactic azithromycin in pregnancy has been shown to lower infections in birthing parents and newborns, particularly skin and soft tissue infections (SSTIs) which are common in Fiji. We...
bmcmedicine.biomedcentral.com
April 29, 2025 at 1:53 PM
Our new paper on the efficacy of 1 dose of Azithromycin given to 2100 pregnant women in labour on infant skin & soft tissue infections in Fiji: blinded, placebo RCT
Congratulations to Maeve, Steph, Tupou & the team
bmcmedicine.biomedcentral.com/articles/10....
Congratulations to Maeve, Steph, Tupou & the team
bmcmedicine.biomedcentral.com/articles/10....
The Pacific Paediatric Conference is on 25-27 April
I look forward to speaking on
Sustaining Resilient Immunisation Policy, Including During Times of Crises
www.pacificpaediatrics.com/events
I look forward to speaking on
Sustaining Resilient Immunisation Policy, Including During Times of Crises
www.pacificpaediatrics.com/events
April 21, 2025 at 5:35 PM
The Pacific Paediatric Conference is on 25-27 April
I look forward to speaking on
Sustaining Resilient Immunisation Policy, Including During Times of Crises
www.pacificpaediatrics.com/events
I look forward to speaking on
Sustaining Resilient Immunisation Policy, Including During Times of Crises
www.pacificpaediatrics.com/events
The power of vaccines- one of the greatest public health success stories of the last century.
Their success shown in 3 charts 👇
www.nature.com/articles/d41...
Their success shown in 3 charts 👇
www.nature.com/articles/d41...
April 9, 2025 at 7:08 AM
The power of vaccines- one of the greatest public health success stories of the last century.
Their success shown in 3 charts 👇
www.nature.com/articles/d41...
Their success shown in 3 charts 👇
www.nature.com/articles/d41...
At the 2nd Global Clinical Trials Forum this week, the action plan for clinical trial strengthening was discussed
Now more than ever is good quality research needed to inform health policy.
Other @WHO clinical trial resources and tools are here:
www.who.int/our-work/sci...
Now more than ever is good quality research needed to inform health policy.
Other @WHO clinical trial resources and tools are here:
www.who.int/our-work/sci...
Strengthening clinical trials
www.who.int
April 3, 2025 at 6:24 PM
At the 2nd Global Clinical Trials Forum this week, the action plan for clinical trial strengthening was discussed
Now more than ever is good quality research needed to inform health policy.
Other @WHO clinical trial resources and tools are here:
www.who.int/our-work/sci...
Now more than ever is good quality research needed to inform health policy.
Other @WHO clinical trial resources and tools are here:
www.who.int/our-work/sci...
Investment in early childhood is highly cost-effective with changes to lifelong health
But there’s knowledge gaps
Children are often missing from trials
Our paper on how to improve this situation
t.co/KxCc2qk9CF
But there’s knowledge gaps
Children are often missing from trials
Our paper on how to improve this situation
t.co/KxCc2qk9CF
March 27, 2025 at 5:51 AM
Investment in early childhood is highly cost-effective with changes to lifelong health
But there’s knowledge gaps
Children are often missing from trials
Our paper on how to improve this situation
t.co/KxCc2qk9CF
But there’s knowledge gaps
Children are often missing from trials
Our paper on how to improve this situation
t.co/KxCc2qk9CF
The Pacific Paediatric Conference is coming up soon
Honoured to be invited & to talk on this important topic:
Sustaining Resilient Immunisation Policy including during times of crises
www.pacificpaediatrics.com/events
Honoured to be invited & to talk on this important topic:
Sustaining Resilient Immunisation Policy including during times of crises
www.pacificpaediatrics.com/events
March 18, 2025 at 10:23 PM
The Pacific Paediatric Conference is coming up soon
Honoured to be invited & to talk on this important topic:
Sustaining Resilient Immunisation Policy including during times of crises
www.pacificpaediatrics.com/events
Honoured to be invited & to talk on this important topic:
Sustaining Resilient Immunisation Policy including during times of crises
www.pacificpaediatrics.com/events
US CDC’s plan to study measles vaccine & autism is yet another example of research waste
This Q has already been answered in many studies
There is no link between measles vaccine & autism
But there is a big link between measles infection & death
publications.aap.org/aapnews/news...
This Q has already been answered in many studies
There is no link between measles vaccine & autism
But there is a big link between measles infection & death
publications.aap.org/aapnews/news...
March 11, 2025 at 8:42 PM
US CDC’s plan to study measles vaccine & autism is yet another example of research waste
This Q has already been answered in many studies
There is no link between measles vaccine & autism
But there is a big link between measles infection & death
publications.aap.org/aapnews/news...
This Q has already been answered in many studies
There is no link between measles vaccine & autism
But there is a big link between measles infection & death
publications.aap.org/aapnews/news...
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
And even more poorly prepared if it’s a virus that effects children - like influenza - which it will be one day
theconversation.com/5-years-sinc...
And even more poorly prepared if it’s a virus that effects children - like influenza - which it will be one day
theconversation.com/5-years-sinc...
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
It’s more than likely we’ll face another pandemic in the future. So what can we learn from COVID?
theconversation.com
March 11, 2025 at 9:16 AM
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
And even more poorly prepared if it’s a virus that effects children - like influenza - which it will be one day
theconversation.com/5-years-sinc...
And even more poorly prepared if it’s a virus that effects children - like influenza - which it will be one day
theconversation.com/5-years-sinc...
Should science be political?
“Instead of asking whether science should be political, we should ask how politics can be more scientific”
www.thelancet.com/journals/lan...
“Instead of asking whether science should be political, we should ask how politics can be more scientific”
www.thelancet.com/journals/lan...
Should science be political?
At this point in time, with US President Trump's administration attacking institutions
such as the US CDC, NIH, USAID, WHO, and their people and functions, whether science
should be political seems li...
www.thelancet.com
March 10, 2025 at 8:35 AM
Should science be political?
“Instead of asking whether science should be political, we should ask how politics can be more scientific”
www.thelancet.com/journals/lan...
“Instead of asking whether science should be political, we should ask how politics can be more scientific”
www.thelancet.com/journals/lan...
French study on break through RSV
during monoclonal antibody use, nirsevimab.
RSV-A infections did not reveal any substitution in sites known to be associated with resistance.
2/24 RSV-B breakthrough infections had resistance-associated substitutions
www.thelancet.com/journals/lan...
during monoclonal antibody use, nirsevimab.
RSV-A infections did not reveal any substitution in sites known to be associated with resistance.
2/24 RSV-B breakthrough infections had resistance-associated substitutions
www.thelancet.com/journals/lan...
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study
This study is, to the best of our knowledge, the largest genotypic and phenotypic
surveillance study of nirsevimab breakthrough infections to date. Nirsevimab breakthrough
variants remain very rare de...
www.thelancet.com
March 10, 2025 at 8:31 AM
French study on break through RSV
during monoclonal antibody use, nirsevimab.
RSV-A infections did not reveal any substitution in sites known to be associated with resistance.
2/24 RSV-B breakthrough infections had resistance-associated substitutions
www.thelancet.com/journals/lan...
during monoclonal antibody use, nirsevimab.
RSV-A infections did not reveal any substitution in sites known to be associated with resistance.
2/24 RSV-B breakthrough infections had resistance-associated substitutions
www.thelancet.com/journals/lan...
